Non-invasive Parameters Or Liver Biopsy In The Diagnosis And Staging Of Non-alcoholic Fatty Liver Disease? | 3409
Journal of Gastrointestinal & Digestive System
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease worldwide and its prevalence
continues to increase with the growing outbreak of obesity. NAFLD includes wide spectrum of diseases from fully benign simple
steatosis to steatohepatitis, which could progress to liver cirrhosis and hepatocellular carcinoma. Liver biopsy is considered as the
gold standard for assessing disease severity. Recently non-invasive parameters are considered to substitute liver biopsy in evaluation of
inflammation and fibrosis. The aim of our study was to assess the diagnostic value of serum markers of fibrosis and inflammation in
patients with NASH.
Patients & Methods:
Serum concentrations of hyalurinic acid (HA), cytokeratine-18 fragments, TIMP1 and P3NP were measured and
index Hepascore was calculated in 88 patients with NASH indicated for liver biopsy; in 10 patients measurement of hepatic venous
pressure gradient was performed.
The values of examined parameters were significantly elevated in patients with NASH compare to controls. Significant difference
in HA, Hepascore and other parameters was found between cirrhosis and all other fibrosis stages (p<0.05). HA discriminated cirrhosis
with AUC 0.996 (sensitivity 94% and specificity 95%) and correlated with the degree of portal hypertension (p=0.002).
Significant differences of serum parameters of fibrosis and inflammation were found between patients with NASH with
different degrees of fibrosis and controls. Examination of serum HA could discriminate patients with cirrhosis without liver biopsy and
could evaluate the degree of portal hypertension. Supported by IGA MZCR: NT 11247/4 and NT 12290/4.
Radan Bruha has completed his Ph.D. at the age of 31 years from Charles University in Prague. He has conducted his postdoctoral studies at
Medical School of Charles University. At present he is the head of hepatogastroenterology department at 4
Internal Clinic, General Teaching
Hospital, Charles University in Prague. He has published more than 20 papers in reputed journals on the topic of liver and biliary diseases and has
presented his work at international congresses. He is serving as a reviewer and an editorial board member for repute international journals.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals